Owlstone Medical announces $27 million USD first close in Series E financing round - PharmaTimes Funds to accelerate commercialisation and clinical trials of diagnostic tests

#OwlstoneMedical @OwlstoneMedical #BreathBiopsy #breathbaseddiagnostics #pointofcarediagnostics #POCdiagnostics #lungcancer #liverdisease #breathbaseddiagnostics #LIBRAtest #OMEDHealthBreathAnalyzer #VOCAtlasdatabase #diseasedetection #precisionmedicine
pharmatimes.com/news/owlston...